Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BP1.3656 for Alcohol Use Disorder
2017-000069-57Phase 2Completed
- Sponsor
- Bioprojet
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of BP1.3656 in alcohol use disorder (AUD) (4 arms), sponsored by Bioprojet. Primary endpoint: Change in monthly heavy drinking days. Started May 2017; status: completed.
02
Drugs
BP1.3656
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on 2017-000069-57.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000069-57.